Bioaffinity Technologies, INC. (BIAFW) — DEF 14A Filings

All DEF 14A filings from Bioaffinity Technologies, INC.. Browse 5 Proxy Statement reports with AI-powered summaries and risk analysis.

DEF 14A Filings (5)

BioAffinity Seeks Shareholder Nod for Major Dilution, Equity Plan Boost — Nov 7, 2025 Risk: high
bioAffinity Technologies, Inc. (BIAFW) is holding a Special Meeting of Stockholders on December 19, 2025, to address several critical financial and equity-relat
bioAffinity Pushes Early Lung Cancer Dx; Annual Meeting Set — Jun 2, 2025 Risk: medium
bioAffinity Technologies, Inc. filed a Definitive Proxy Statement (DEF 14A) on June 2, 2025, for its Annual Meeting of Stockholders scheduled for July 25, 2025,
bioAffinity Technologies Files Definitive Proxy Statement — Nov 22, 2024 Risk: low
bioAffinity Technologies, Inc. filed a Definitive Proxy Statement (DEF 14A) on November 22, 2024. This filing is related to the company's proxy materials, which
bioAffinity Technologies Files Definitive Proxy Statement — Sep 5, 2024 Risk: low
bioAffinity Technologies, Inc. filed a definitive proxy statement (DEF 14A) on September 5, 2024. The filing concerns the company's annual meeting and related m
bioAffinity Technologies Announces Annual Meeting of Stockholders on June 4, 2024 — Apr 15, 2024 Risk: low
bioAffinity Technologies, Inc. (BIAFW) filed a Proxy Statement (DEF 14A) with the SEC on April 15, 2024. bioAffinity Technologies, Inc. will hold its Annual Mee

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX